Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study

被引:157
作者
Zarski, Jean-Pierre [1 ,2 ]
Sturm, Nathalie [2 ,3 ]
Guechot, Jerome [4 ]
Paris, Adeline [5 ]
Zafrani, Elie-Serge [6 ]
Asselah, Tarik [7 ]
Boisson, Renee-Claude [8 ]
Bosson, Jean-Luc [5 ]
Guyader, Dominique [9 ]
Renversez, Jean-Charles [10 ]
Bronowicki, Jean-Pierre [11 ]
Gelineau, Marie-Christine [12 ]
Tran, Albert [13 ]
Trocme, Candice [14 ]
De Ledinghen, Victor [15 ]
Lasnier, Elisabeth
Poujol-Robert, Armelle [16 ]
Ziegler, Frederic [17 ]
Bourliere, Marc [18 ]
Voitot, Helene [19 ]
Larrey, Dominique [20 ]
Rosenthal-Allieri, Maria Alessandra [21 ]
Hubert, Isabelle Fouchard [22 ]
Bailly, Francois [23 ]
Vaubourdolle, Michel [4 ]
机构
[1] Clin Univ Hepatogastroenterol Pole DIGIDUNE CHU, F-38043 Grenoble 9, France
[2] Unite INSERM UJF IAPC Inst Albert Bonniot Grenobl, Grenoble, France
[3] CHU Grenoble, Dept Anat & Cytol Pathol Pole Biol, F-38043 Grenoble, France
[4] Hop St Antoine, AP HP, Lab Biochim A, F-75571 Paris, France
[5] CHU Grenoble, Ctr Invest Clin INSERM CIC003, F-38043 Grenoble, France
[6] Univ Paris Est, Hop Henri Mondor, Assistance Publ Hop Paris, Dept Pathol, Creteil, Val De Marne, France
[7] Hop Beaujon, AP HP, Serv Hepatogastroenterol, Clichy, France
[8] Hosp Civils Lyon, Lab Biochim, Ctr Hosp Lyon Sud, Lyon, France
[9] CHU Rennes, Serv Hepatol, Rennes, France
[10] CHU Grenoble, Dept Biol Integree, F-38043 Grenoble, France
[11] CHU Nancy, Serv Hepatogastroenterol, Nancy, France
[12] Hosp Civils Lyon, Hotel Dieu, Lab Biochim, Lyon, France
[13] Hop Archet 2, Nice, France
[14] Univ Grenoble, GREPI TIMC IMAG UMR CNRS 5525, Lab Enzymol, Dept Biol & Pathol Cellule,CHU Grenoble, Grenoble, France
[15] CHU Bordeaux, Serv Hepatogastroenterol, Bordeaux, France
[16] Hop St Antoine, AP HP, Serv Hepatogastroenterol, F-75571 Paris, France
[17] IFR23 CHU, IHU, EA4311, Lab Biochim,Inst Biol Clin, Rouen, France
[18] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France
[19] Hop Beaujon, AP HP, Lab Biochim, Clichy, France
[20] CHU Montpellier, Serv Hepatogastroenterol, Montpellier, France
[21] CHU Nice, Lab Immunol, Nice, France
[22] CHU Angers, Serv Hepatogastroenterol, Angers, France
[23] Hotel Dieu Lyon, Serv Hepatogastroenterol, Lyon, France
关键词
Chronic hepatitis C; Liver fibrosis; Surrogate markers; Transient elastography; Blood tests; CHRONIC VIRAL-HEPATITIS; DIAGNOSTIC-ACCURACY; NONINVASIVE ASSESSMENT; BIOCHEMICAL MARKERS; CLINICAL-PRACTICE; SERUM MARKERS; BIOPSY; CIRRHOSIS; VARIABILITY; FIBROTEST;
D O I
10.1016/j.jhep.2011.05.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Blood tests and transient elastography (Fibroscan T) have been developed as alternatives to liver biopsy. This ANRS HCEP-23 study compared the diagnostic accuracy of nine blood tests and transient elastography (Fibroscan T) to assess liver fibrosis, vs. liver biopsy, in untreated patients with chronic hepatitis C (CHC). Methods: This was a multicentre prospective independent study in 19 French University hospitals of consecutive adult patients having simultaneous liver biopsy, biochemical blood tests (performed in a centralized laboratory) and Fibroscan (TM). Two experienced pathologists independently reviewed the liver biopsies (mean length = 25 +/- 8.4 mm). Performance was assessed using ROC curves corrected by Obuchowski's method. Results: Fibroscan (TM) was not interpretable in 113 (22%) patients. In the 382 patients having both blood tests and interpretable Fibroscan (TM), Fibroscan (TM) performed similarly to the best blood tests for the diagnosis of significant fibrosis and cirrhosis. Obuchowski's measure showed Fibrometer (R) (0.86), Fibrotest (R) (0.84), Hepascore (R) (0.84), and interpretable Fibroscan (TM) (0.84) to be the most accurate tests. The combination of Fibrotest (R), Fibrometer (R), or Hepascore (R) with Fibroscan (TM) or Apri increases the percentage of well classified patients from 70-73% to 8083% for significant fibrosis, but for cirrhosis a combination offers no improvement. For the 436 patients having all the blood tests, AUROC's ranged from 0.82 (Fibrometer (R)) to 0.75 (Hyaluronate) for significant fibrosis, and from 0.89 (Fibrometer (R) and Hepascore (R)) to 0.83 (FIB-4) for cirrhosis. Conclusions: Contrarily to blood tests, performance of Fibroscan T was reduced due to uninterpretable results. Fibrotest (R), interpretable Fibroscan (TM), Fibrometer (R), and Hepascore (R) perform best and similarly for diagnosis of significant fibrosis and cirrhosis. (C) 2011 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 44 条
  • [1] Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection
    Adams, LA
    Bulsara, M
    Rossi, E
    Deboer, B
    Speers, D
    George, J
    Kench, J
    Farrell, G
    McCaughan, GW
    Jeffrey, GP
    [J]. CLINICAL CHEMISTRY, 2005, 51 (10) : 1867 - 1873
  • [2] Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States
    Becker, Laren
    Salameh, Wael
    Sferruzza, Anthony
    Zhang, Ke
    Chen, Rong
    Malik, Raza
    Reitz, Richard
    Nasser, Imad
    Afdhal, Nezam H.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (06) : 696 - 701
  • [3] An algorithm for the grading of activity in chronic hepatitis C
    Bedossa, P
    Poynard, T
    [J]. HEPATOLOGY, 1996, 24 (02) : 289 - 293
  • [4] Sampling variability of liver fibrosis in chronic hepatitis C
    Bedossa, P
    Dargère, D
    Paradis, V
    [J]. HEPATOLOGY, 2003, 38 (06) : 1449 - 1457
  • [5] BEDOSSA P, 1994, HEPATOLOGY, V20, P15
  • [6] Liver biopsy: The best, not the gold standard
    Bedossa, Pierre
    Carrat, Fabrice
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (01) : 1 - 3
  • [7] Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies
    Bourliere, M.
    Penaranda, G.
    Renou, C.
    Botta-Fridlund, D.
    Tran, A.
    Portal, I.
    Lecomte, L.
    Castellani, P.
    Rosenthal-Allieri, M. A.
    Gerolami, R.
    Ouzan, D.
    Deydier, R.
    Degott, C.
    Halfon, P.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 659 - 670
  • [8] The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis
    Boursier, Jerome
    Vergniol, Julien
    Sawadogo, Apollinaire
    Dakka, Taoufiq
    Michalak, Sophie
    Gallois, Yves
    Le Tallec, Veronique
    Oberti, Frederic
    Fouchard-Hubert, Isabelle
    Dib, Nina
    Rousselet, Marie Christine
    Konate, Anselme
    Amrani, Naima
    de Ledinghen, Victor
    Cales, Paul
    [J]. LIVER INTERNATIONAL, 2009, 29 (10) : 1507 - 1515
  • [9] Practices of liver biopsy in France: Results of a prospective nationwide survey
    Cadranel, JF
    Rufat, P
    Degos, F
    [J]. HEPATOLOGY, 2000, 32 (03) : 477 - 481
  • [10] A novel panel of blood markers to assess the degree of liver fibrosis
    Calès, P
    Oberti, F
    Michalak, S
    Hubert-Fouchard, I
    Rousselet, MC
    Konat, A
    Gallois, Y
    Ternisien, C
    Chevailler, A
    Lunel, F
    [J]. HEPATOLOGY, 2005, 42 (06) : 1373 - 1381